Recommendations of the RUSA Expert Committee to finalize choice based courses and course content in the vertical of Pharmacy.

Recommendations of the RUSA Expert Committee to finalize choice based courses and course content in the vertical of Pharmacy.

Core Committee Members:

1. Dr. Anuradha Majumdar, Associate Professor of Pharmacology, Bombay College of Pharmacy, Mumbai, Chairperson
2. Dr. P. R. Vavia, Professor of Pharmaceutics and Dean, Academic Programmes, Institute of Chemical Technology, Mumbai
3. Dr. Sanish Davis, Country Head and Senior Medical Director, Covance
4. Dr. Mandar Kodgule, Ex VP, Global IP and Corporate strategy, Wockhardt Ltd, Chairman and CEO, IQGEN-X Pharma Pvt Ltd.
5. Dr. Stephen D‟Silva, Professor of Marketing Management, Jamnalal Bajaj Institute of Management Studies

Taking into cognizance the suggestions of academicians and Industry key opinion leaders, the committee is recommending seven choice based Courses, namely:

1. Clinical Data Management
2. Industrial Pharmacy I
3. Industrial Pharmacy II
4. Industrial Pharmacy III
5. Pharmaceutical Marketing Management
6. Pharmaceutical Product Management
7. Pharmaceutical Business Innovation Management

  • Each course is of 3 credit points, with total 45 hours of lectures/tutorials.

  • All the seven courses can be introduced between sem. V to sem. VIII in the B Pharm Programme.

  • Students can opt for the courses based on their interests and prospective career choices.

  • The course of Clinical Data Management (CDM) can also be offered as elective to B.Sc (Any Biological Sciences), in TY B.Sc (Sem V or Sem VI).

  • The courses of Pharmaceutical Marketing Management, Pharmaceutical Product Management, and Pharmaceutical Business Innovation Management can also be offered as electives to B.Sc. (Any Biological Sciences) in TY B.Sc (Sem V or Sem VI).